EVALUATION OF THE MOLECULAR-BIOLOGICAL PROPERTIES OF HUMAN ROTAVIRUS A STRAIN WA

Cover Page


Cite item

Full Text

Abstract

Introduction. Rоtaviruses are amоng the leading causes of severe diarrhea in children all over the Wоrld. Vaccination is considered to be the mоst effective way to cоntrоl the disease. Currently available vaccines for prevention of rоtavirus infection are based on live attenuated rotavirus strains human оr animal origin. Objectives and purposes. The aim of this investigation was to study the biological and genetic properties of an actual epidemic human rotavirus A (RVA) strain Wa G1P[8] genotype. Material and methods. RVA Wa reproduction in a monolayer continuous cell lines, purification and concentration of RVA antigen, PAAG electrophoresis and Western-Blot, electrophoresis of viral genomic RNA segments, sequencing. Results. Human RVA G1P[8] Wa strain biological and molecular genetic properties were assessed in the process of the adaptation to MARC145 continuous cell line. Cell cultured RVA antigen was purified, concentrated and then characterized by the method of PAAG electrophoresis and immunoblot. To verify RVA Wa genome identity, electrophoresis of viral genomic RNA segments was performed. The lack of accumulation of changes in the RVA Wa genome during adaptation to various cell cultures and during serial passages was demonstrated by sequencing fragments of the viral genome. Conclusion. RVA Wa strain is stable, it possesses high biological activity: it has been successfully adapted to the MARC145 cell line and RVA Wa virus titer after the adaptation reached 7,5-7,7 lg TCID50/ml. The identity of the cultivated RVA to the original strain Wa G1P[8] was confirmed.

About the authors

K. M. Khametova

Ivanovsky Virology Institute, «National Research Center for Epidemiology and Microbiology named after the honorary academician NF. Gamaleya»

Author for correspondence.
Email: kizkhalum@yandex.ru
Russian Federation

K. P. Alekseev

Ivanovsky Virology Institute, «National Research Center for Epidemiology and Microbiology named after the honorary academician NF. Gamaleya»

Email: noemail@neicon.ru
Russian Federation

A. G. Yuzhakov

Ivanovsky Virology Institute, «National Research Center for Epidemiology and Microbiology named after the honorary academician NF. Gamaleya»

Email: noemail@neicon.ru
Russian Federation

L. V. Kostina

Ivanovsky Virology Institute, «National Research Center for Epidemiology and Microbiology named after the honorary academician NF. Gamaleya»

Email: noemail@neicon.ru
Russian Federation

S. A. Raev

Ivanovsky Virology Institute, «National Research Center for Epidemiology and Microbiology named after the honorary academician NF. Gamaleya»

Email: noemail@neicon.ru
Russian Federation

M. I. Musienko

Ivanovsky Virology Institute, «National Research Center for Epidemiology and Microbiology named after the honorary academician NF. Gamaleya»

Email: noemail@neicon.ru
Russian Federation

A. N. Mukhin

Ivanovsky Virology Institute, «National Research Center for Epidemiology and Microbiology named after the honorary academician NF. Gamaleya»

Email: noemail@neicon.ru
Russian Federation

T. I. Aliper

Ivanovsky Virology Institute, «National Research Center for Epidemiology and Microbiology named after the honorary academician NF. Gamaleya»

Email: noemail@neicon.ru
Russian Federation

G. K. Vorkunova

Ivanovsky Virology Institute, «National Research Center for Epidemiology and Microbiology named after the honorary academician NF. Gamaleya»

Email: noemail@neicon.ru
Russian Federation

T. V. Grebennikova

Ivanovsky Virology Institute, «National Research Center for Epidemiology and Microbiology named after the honorary academician NF. Gamaleya»; Peoples Frendship University of Russia (RUDN)

Email: noemail@neicon.ru
Russian Federation

References

  1. Walker C.L.F., Rudan I., Liu L., Nair H., Theodoratou E., Bhutta Z.A., et al. Global burden of childhood pneumonia and diarrhoea. Lancet. 2013; 381(9875): 1405-16. doi: 10.1016/S0140-6736(13)60222-6
  2. Liu L., Oza S., Hogan D., Perin J., Rudan I., Lawn J.E., et al. Global, regional, and national causes of child mortality in 2000-13, with projections to inform post-2015 priorities: an updated systematic analysis. Lancet. 2015; 385(9966): 430-40. doi: 10.1016/S0140-6736(14)61698-6
  3. Алексеев К.П., Кальнов С.Л., Гребенникова Т.В., Алипер Т.И. Ротавирусная инфекция человека. Стратегии вакцинопрофилактики. Вопросы вирусологии. 2016; 61(3): 154-9
  4. Sanderson C., Clark A., Taylor D., Bolanos B. Global review of rotavirus morbidity and mortality data by age and region. WHO; 2011. Available at: https://www.who.int/immunization/sage/meetings/2012/april/Sanderson_et_al_SAGE_April_rotavirus.pdf
  5. Tate J.E., Burton A.H., Boschi-Pinto C., Parashar U.D. Global, regional, and national estimates of rotavirus mortality in children №5 years of age, 2000-2013. Clin. Infect. Dis. 2016; 62(Suppl. 2): S96-S105. doi: 10.1093/cid/civ1013
  6. Gurwith M., Wenman W., Hinde D., Feltham S., Greenberg H. A prospective study of rotavirus infection in infants and young children. J. Infect. Dis. 1981; 144(3): 218-24.
  7. Колпаков С.А., Колпакова Е.П. Адаптация штаммов ротавируса человека группы А и репродукция на перевиваемых культурах клеток. Вопросы вирусологии. 2017; 62(3): 138-43.
  8. Бахтояров Г.Н., Лободанов С.А., Марова А.А., Мескина Е.Р., Зверев В.В., Файзулоев Е.Б. Определение генетической структуры ротавирусов группы А, циркулирующих в Московском регионе, методом ПЦР в режиме реального времени. Эпидемиология и вакцинопрофилактика. 2012; 67(3): 35-9.
  9. Crawford S.E., Ramani S., Tate J.E., Parashar U.D., Svensson L., Hagbom M., et al. Rotavirus infection. Nat. Rev. Dis. Primers. 2017; 3: 17083. doi: 10.1038/nrdp.2017.83
  10. Лукьянова А.М., Бехтерева М.К., Птичникова Н.Н. Клинико-эпидемиологическая характеристика вирусных диарей у детей. Журнал инфектологии. 2014; 6(1): 60-6
  11. Kotloff K.L., Nataro J.P., Blackwelder W.C., Nasrin D., Farag T., Panchalingam S., et al. Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the global multicenter study, GEMS): a prospective, case control study. Lancet. 2013; 382(9888): 209-22. doi: 10.1016/S0140-6736(13)60844-2
  12. Matthijnssens J., Otto P.H., Ciarlet M., Desselberger U., Van Ranst M., Johne R. VP6-sequence-based cutoff values as a criterion for rotavirus species demarcation. Arch. Virol. 2012; 157(6): 1177-82. doi: 10.1007/s00705-012-1273-3
  13. Bhat S., Kattoor J., Malik Y., Sircar S., Deol P., Rawat V., et al. Species C Rotaviruses in Children with Diarrhea in India, 2010-2013: A Potentially Neglected Cause of Acute Gastroenteritis. Pathogens. 2018; 7(1): 1-14. doi: 10.3390/pathogens7010023
  14. Estes M.K., Greenberg H.B. Rotaviruses. In: Knipe D.M., Howley P.M., eds. Fields Virology. Philadelphia: Lippincott, Williams & Wilkins; 2013: 1347-401.
  15. Кондакова О.А., Никитин Н.А., Трифонова Е.А., Атабеков И.Г., Карпова О.В. Вакцины против ротавируса: новые стратегии и разработки. Вестник Московского университета. Серия 16. Биология. 2017; 72(4): 199-208
  16. Parashar U.D., Hummelman E.G., Bresee J.S., Miller M.A., Glass R.I. Global illness and deaths caused by rotavirus disease in children. Emerg. Infect. Dis. 2003; 9(5): 565-72.
  17. Walker C.L., Taneja S., LeFevre A., Black R.E., Mazumder S. Appropriate Management of Acute Diarrhea in Children Among Public and Private Providers in Gujarat, India: A Cross-Sectional Survey. Glob. Health Sci. Pract. 2015; 3(2): 230-41. doi: 10.9745/GHSP-D-14-00209
  18. Rotavirus Classification Working Group: RCWG. KU Leuven Laboratory of Viral Metagenomics. 2017. Available at: https://rega.kuleuven.be/cev/viralmetagenomics/virus-classification/rcwg
  19. Matthijnssens J., Bilcke J., Ciarlet M., Martella V., Bányai K., Rahman M., et al. Rotavirus disease and vaccination: impact on genotype diversity. Future Microbiol. 2009; 4(10): 1303-16. doi: 10.2217/fmb.09.96
  20. Santos N., Hoshino Y. Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccine. Rev. Med. Virol. 2005; 15(1): 29-56. doi: 10.1002/rmv.448
  21. Gentsch J.R., Laird A.R., Bielfelt B., Griffin D.D., Banyai K., Ramachandran M., et al. Serotype diversity and reassortment between human and animal rotavirus strains: implications for rotavirus vaccine programs. J. Infect. Dis. 2005; 192(Suppl. 1): S146-59. doi: 10.1086/431499
  22. Matthijnssens J., Heylen E., Zeller M., Rahman M., Lemey P., Van Ranst M. Phylodynamic analyses of rotavirus genotypes G9 and G12 underscore their potential for swift global spread. Mol. Biol. Evol. 2010; 27(10): 2431-6. doi: 10.1093/molbev/msq137
  23. Зайцева Е.В., Ольнева Т.А., Кулешов К.В., Подколзин А.Т., Шипулин Г.А., Кондратьева Л.М. и др. Результаты мониторинга антигенных типов ротавирусов гр. А на территории Российской Федерации в период 2011-2015 гг. Клиническая лабораторная диагностика. 2016; 61(7): 445-8. doi: 10.18821/0869-2084-2016-61-7-445-448
  24. Денисюк Н.Б. Генетическая характеристика ротавирусов группы А, циркулирующих в Оренбургском регионе в сезон 2016-2017 гг. Детские инфекции. 2017; 16(4): 42-5.
  25. Zhang J., Liu H., Jia L., Payne D.C., Hall A.J., Xu Z., et al. Active, population-based surveillance for rotavirus gastroenteritis in Chinese children: Beijing Municipalityand Gansu Province, China. Pediatr. Infect. Dis. J. 2015; 34(1): 40-6. doi: 10.1097/INF.0000000000000505.
  26. Liu N., Xu Z., Li D., Zhang G., Wang H., Duan Z.J. Update on the disease burden and circulating strains of rotavirus in China: a systematic review and meta-analysis. Vaccine. 2014; 32(35): 4369-75. doi: 10.1016/j.vaccine.2014.06.018
  27. Баранов А.А., Намазова-Баранова Л.С., Таточенко В.К., Вишнёва Е.А., Федосеенко М.В., Селимзянова Л.Р. и др. Ротавирусная инфекция у детей - нерешенная проблема. Обзор рекомендаций по вакцинопрофилактике. Педиатрическая фармакология. 2017; 14(4): 248-57. doi: 10.15690/pf.v14i4.1756
  28. Xue M., Yu L., Che Y., Lin H., Zeng Y., Fang M., et al. Characterization and protective efficacy in animal model of novel truncated rotavirus VP8 subunit parenteral vaccine candidate. Vaccine. 2015; 33(22): 2606-13. doi: 10.1016/j.vaccine.2015.03.068
  29. World Health Organization. Information sheet. Observed rate of vaccine reactions - Rotavirus Vaccine. 2018. Available at: https://www.who.int/vaccine_safety/initiative/tools/Rotavirus_vaccine_rates_information_sheet_0618.pdf
  30. Rippinger C.M., Patton J.T., McDonald S.M. Complete genome sequence analysis of candidate human rotavirus vaccine strains RV3 and 116E. Virology. 2010; 405(1): 201-13. doi: 10.1016/j.virol.2010.06.005
  31. Desselberger U. Rotaviruses. Virus Res. 2014; 190: 75-96. doi: 10.1016/j.virusres.2014.06.016
  32. WHO. Rotavirus vaccines: an update. Wkly. Epidemiol. Rec. 2012; 84(51-52): 533-37.
  33. Bucardo F., Rippinger C.M., Svensson L., Patton J.T. Vaccine-derived NSP2 segment in rotaviruses from vaccinated children with gastroenteritis in Nicaragua. Infect. Genet. Evol. 2012; 12(6): 1282-94. doi: 10.1016/j.meegid.2012.03.007
  34. Hemming M., Vesikari T. Detection of rotateq vaccine-derived, double-reassortant rotavirus in a 7-year-old child with acute gastroenteritis. Pediatr. Infect. Dis. J. 2014; 33(6): 655-6. doi: 10.1097/INF.0000000000000221.
  35. Soma J., Tsunemitsu H., Miyamoto T., Suzuki G., Sasaki T., Suzuki T. Whole-genome analysis of two bovine rotavirus C strains: Shintoku and Toyama. J. Gen. Virol. 2013; 94(Pt. 1):128-35. doi: 10.1099/vir.0.046763-0
  36. Ward L.A., Rosen B.I., Yuan L., Saif L.J. Pathogenesis of an attenuated and a virulent strain of group A human rotavirus in neonatal gnotobiotic pigs. J. Gen. Virol. 1996; 77(Pt. 7): 1431-41. doi: 10.1099/0022-1317-77-7-1431.
  37. Ghosh S., Alam M.M., Ahmed M.U., Talukdar R.I., Paul S.K., Kobayashi N. Complete genome constellation of a caprinegroup A rotavirus strain reveals common evolution withruminant and human rotavirus strains. J. Gen. Virol. 2010; 91(Pt. 9): 2367-73. doi: 10.1099/vir.0.022244-0
  38. Azevedo M.P., Vlasova A.N., Saif L.J. Human rotavirus virus-like particle vaccines evaluated in a neonatal gnotobiotic pig model of human rotavirus disease. Expert Rev. Vaccines. 2013; 12(2): 169-81. doi: 10.1586/erv.13.3
  39. Friess A.E., Sinowatz F., Skolek-Winnisch R., Träutner W. The placenta of the pig. II. The ultrastructure of the areolae. Anat. Embryol. (Berl.) 1981; 163(1): 43-53.
  40. Lala P.K., Chatterjee-Hasrouni S., Kearns M., Montgomery B., Colavincenzo V. Immunobiology of the feto-maternal interface. Immunol. Rev. 1983; 75: 87-116.
  41. Yuan L., Ward L.A., Rosen B.I., To T.L., Saif L.J. Systematic and intestinal antibodysecreting cell responses and correlates of protective immunity to human rotavirus in a gnotobiotic pig model of disease. J. Virol. 1996; 70(5): 3075-83.
  42. Burns J.W., Krishnaney A.A., Vo P.T., Rouse R.V., Anderson L.J., Greenberg H.B. Analyses of homologous rotavirus infection in the mouse model. Virology. 1995; 207(1): 143-53. doi: 10.1006/viro.1995.1060.
  43. Ciarlet M., Conner M.E., Finegold M.J., Estes M.K. Group A rotavirus infection and age-dependent diarrheal disease in rats: a new animal model to study the pathophysiology of rotavirus infection. J. Virol.2002; 76(1): 41-57.
  44. Wyatt R.G., James W.D., Bohl E.H., Theil K.W., Saif L.J., Kalica A.R., et al. 1980. Human rotavirus type 2: cultivation in vitro. Science. 1980; 207(4427): 189-91.
  45. Bohl E.H., Salt L.J., Theil K.W., Agnes A.G., Cross R.F. Porcine pararotavirus: detection, differentiation from rotavirus, and pathogenesis in gnotobiotic pigs. J. Clin. Microbiol. 1982; 15(2): 312-9.
  46. WHO. Manual of rotavirus detection and characterization methods. 2009. Available at: https://www.who.int/immunization/monitoring_surveillance/burden/vpd/surveillance_type/sentinel/WHO_IVB_08.17_eng.pdf
  47. Kyhse-Andersen J. Electroblotting of multiple gels: a simple apparatus without buffer tank for rapid transfer of proteins from polyacrylamide to nitrocellulose. J. Biochem. Biophys. Methods. 1984; 10(3-4): 203-9.
  48. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970; 227(5259): 680-5.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2019 Khametova K.M., Alekseev K.P., Yuzhakov A.G., Kostina L.V., Raev S.A., Musienko M.I., Mukhin A.N., Aliper T.I., Vorkunova G.K., Grebennikova T.V.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС77-77676 от 29.01.2020.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies